Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.

Modeling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
A scalable, automation-compatible CIPN-on-a-chip model using iPSC-derived motor neurons to assess chemotherapy-induced neurotoxicity—enabling dose- and time-dependent evaluation for safer cancer treatment development.
